CelLBxHealth plc
ANPCY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.16M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.16 Million |
|---|---|
| Enterprise Value | $608,008.00 |
| Earnings per Share | $-0.48 |
| Beta | 0.14 |
| Outstanding Shares | 32,252,840 |
Return
| Return on Equity | -475.19% |
|---|---|
| Return on Assets | -250.13% |
| Return on Invested Capital | -322.02% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.35 |
| Enterprise Value to EBIT | -0.04 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 2.14 |
| Debt to Equity | 0.32 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Cellbxhealth PLC
119 employees
CEO: Peter Michael Collins
CelLBxHealth plc, formerly known as ANGLE plc until its name change in October 2025, is a medical diagnostics enterprise established in 1994 and headquartered in Guildford, United Kingdom. The company is dedicated to developing advanced ...